期刊文献+

基于UPLC/Q-TOF-MSE方法分析半夏泻心汤的化学成分 被引量:40

UPLC/Q-TOF-MS^E based analysis of chemical composition of Banxia Xiexin decoction
原文传递
导出
摘要 为了全面快速地阐明半夏泻心汤的化学组成及其归属,本文利用超高效液相色谱与串联四极杆飞行时间质谱仪联用技术(UPLC/Q-TOF-MSE)在相同实验条件下对半夏泻心汤及其组方各单味药的色谱图进行比对分析,归属了色谱峰来源,并根据高分辨质谱数据和对照品信息对色谱峰进行指认。从半夏泻心汤色谱图中共鉴定了74个色谱峰,主要成分包括黄酮类、三萜皂苷类、生物碱类、糖苷类等。本研究比较全面地阐明了半夏泻心汤的化学组成,为半夏泻心汤的药效物质基础研究和质量控制奠定了基础。 In order to clarify the chemical composition and source of Banxia Xiexin decoction quickly and comprehensively, whole and individual herbs of Banxia Xiexin decoction were analyzed by ultra-performance liquid chromatography with quadrupole-time-of-flight mass spectrometry (UPLC/Q-TOF-MSe). Under identical experiment conditions, chromatography results were compared between experiment groups. Based on the Q-TOF-MSE analysis, 74 peaks were identified on line. The herbal sources of these peaks were assigned. The results implied that flavonoids, triterpenoid saponins, alkaloids and glycosides were the main components in effective part of Banxia Xiexin decoction. The method established is simple and rapid for elucidation the constituents of Banxia Xiexin decoction and the results could be used for the quality control of Banxia Xiexin decoction.
出处 《药学学报》 CAS CSCD 北大核心 2013年第4期526-531,共6页 Acta Pharmaceutica Sinica
基金 “重大新药创制”科技重大专项资助项目(2012ZX09301-002) 国家自然科学基金资助项目(81274054)
关键词 半夏泻心汤 UPLC 质量控制 Banxia Xiexin decoction UPLC quality control
  • 相关文献

参考文献5

二级参考文献25

  • 1张国华,王延琮,张永友,王磊,张玉奎.高效毛细管电泳测定黄连及成药中小檗碱型生物碱的含量[J].色谱,1995,13(4):247-249. 被引量:42
  • 2刘晓霓,牛欣,司银楚,金秀东.大鼠血中生姜泻心汤黄芩苷含量与胃运动关系研究[J].中国实验方剂学杂志,2006,12(2):32-34. 被引量:3
  • 3越皓,皮子凤,宋凤瑞,刘志强,刘淑莹.附子不同配伍药对中生物碱成分的电喷雾质谱分析[J].药学学报,2007,42(2):201-205. 被引量:65
  • 4Xuan T, Zhang JA, Ahmad I. HPLC method for determination of SN -38 content and SN -38 entrapment efficiency in a novel liposome-based formulation, LE - SN38 [ J ]. J Pharm Biomed Anal ,2006,41 (2) :582 - 588.
  • 5Akinobu K, Kado S. Kaneda N, et al. Modified irinotecan hydro-chlovide( CPT - 11 ) administration schedule improves induction of delayed - onset diarrhea in rats [ J ]. Cancer chemother phavmacol,2000,46 ( 3 ) :211 - 220.
  • 6Akinobu K, Kado S, Kaneda N, et al. Modified irinotecan hydrochloride ( CPT - 11 ) administration schedule improves induction of delayed - onset diarrhea in rats [ J ]. Cancer Chemother Pharmacol, 2000,46 ( 3 ) : 211 - 220.
  • 7Chiu C J, McArdle AH, Brown R, et al. Intestinal mucosal lesion in low flow states[ J]. Arch Surg, 1970,101 (4):478 -483.
  • 8Santos A, Zanetta S, Crestell T, et al. Metabolism of ifinotecan ( CPT - 11 ) by CYP3 A4 and CYP3A5 In humans[ J ]. Clin Cancer Res,2000,6(5) :2012 -2020.
  • 9Slatter JC, Seheaf LJ, Sams JP, et al. Pharmacokinetics, metabolism,and excretion of ifinotecan( CPT -11 )following I. V. infusion of [ (14) C ] CPT - 11 in cancer Patients [ J ]. Drug Metab Dispos ,2000,28 (4) :423 - 433.
  • 10Trifan OC, Durham WF, Salazar, et al. Cyclooxygenase - 2 Inhibition with celecoxib enhances antitumor efficacy and reduces diarrhea side effect of CPT - 11 [ J ]. Cancer Research, 2002,62 (20) : 5778 -5784.

共引文献88

同被引文献623

引证文献40

二级引证文献472

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部